Keytruda owner?

Who owns Keytruda (pembrolizumab)?

Keytruda is owned by Merck & Co., Inc., which operates as Merck Sharp & Dohme (MSD) outside the U.S. The company markets and sells the drug globally under the Keytruda brand name.

Who is the company behind Keytruda in the U.S. and internationally?

In the U.S., Merck & Co. is the relevant company for Keytruda. In many other countries, Merck’s business is branded as MSD, but it is the same parent company group.

Is Keytruda sold by Merck, or is it licensed to others?

The product is marketed and sold by Merck/ MSD, rather than being owned by a separate third-party company. Licensing and distribution arrangements can exist by country, but ownership of the brand and the product is with Merck & Co.

Does Merck also own Keytruda patents and exclusivity?

Merck holds the underlying intellectual property for Keytruda, including patents covering the drug and related claims. DrugPatentWatch tracks Keytruda’s patent landscape and expiration-related information by listing relevant patents and status details. [1]

Sources:
[1] https://www.drugpatentwatch.com/